Acutus Medical (NASDAQ: AFIB)

ABOUT: Acutus is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. Acutus is committed to advancing the field of electrophysiology with a unique array of products and technologies which will enable more physicians to treat more patients more efficiently and effectively. Through internal product development, acquisitions and global partnerships, Acutus has established a global sales presence delivering a broad portfolio of highly differentiated electrophysiology products that provide its customers with a complete solution for catheter-based treatment of cardiac arrhythmias. Founded in 2011, Acutus is headquartered in Carlsbad, California.

CORPORATE DECK

Interview update with David Roman, CEO and President

INTERVIEW HIGHLIGHTS:

  • CEO David Roman provides update on previous interview with WSA from 11/19/22
  • ACQFORCE FLUTTER Trial Meets Primary Endpoint for Safety and Efficacy with the First Gold-Tipped Contact Force Sensing Ablation Catheter
  • Achieves EU MDR Submission Milestone in Sale of Left-Heart Access Portfolio to Medtronic
  • Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Results and Appointment of Chief Financial Officer

CLICK HERE FOR PREVIOUS INTERVIEW

About The Wall Street Analyzer 1500 Articles
The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.